Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Cipla
Read More
Iran War Puts Global and Indian Healthcare Business, Pharma Stocks on Edge
The escalating conflict between Iran and Israel is sending ripples across the global healthcare ecosystem, with pharmaceutical exports, medical supply…
FTA Hopes Fail to Halt Big Pharma Pullback from India
Novartis AG’s move to exit its small Indian subsidiary once again highlights the limited appetite of global pharmaceutical giants to…
Cipla Names Achin Gupta as Next MD and Global CEO, Effective April 2026
Cipla Limited has announced the appointment of Achin Gupta, currently its Global Chief Operating Officer (GCOO), as the company’s next…
India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Cipla Receives CDSCO Approval to Launch Inhalable Insulin in India
Mumbai – Cipla Limited has received regulatory approval from the Central Drugs Standard Control Organisation (CDSCO) to exclusively distribute and…
Novo Nordisk India Urges Early Wegovy Launch Amid Competition Concerns
Novo Nordisk’s team in India is asking the company’s global leaders to launch its weight-loss drug Wegovy earlier than planned….
Cipla Achieves Record-Breaking Revenue in North America for Q1 FY25
Indian pharmaceutical giant Cipla has achieved a significant milestone in its North American business, reporting a record high revenue of…
Income Tax Demand Notice Issued to Cipla: A Legal Challenge Ahead
On July 12, 2024, Cipla, a prominent pharmaceutical company, received a significant demand notice from the Income Tax Department of…
Cipla Secures Final USFDA Approval for Lanreotide Injection: A Major Step Forward in Treating Hormonal Tumors
Cipla, a global pharmaceutical leader, has recently announced a significant milestone in its mission to provide advanced treatments for hormonal…